Diseases of the Digestive System - Liver | Pregnancy, Childbirth and the Puerperium, Phase 2a/2b
A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)
Volunteers
Health Professionals
What is the purpose of this trial?
The purpose of this clinical research study is to evaluate the efficacy, safety and tolerability of the study medicine, volixibat, in patients with Intrahepatic cholestasis of pregnancy (ICP) and elevated serum bile acid concentrations.
- Trial withMirum Pharmaceuticals Inc.
- Ages18 years - 45 years
- GenderFemale only
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.
- Last Updated04/09/2024
- Study HIC#2000029456